SB708: Bill Text

LRB-4637/1

MED:amn&ahe

2015 - 2016 LEGISLATURE

2015 Senate BILL 708

February 9, 2016 - Introduced by Senators Vukmir and Darling, cosponsored by Representatives Thiesfeldt and Nygren. Referred to Committee on Health and Human Services.

SB708,1,3 An Act to amend 450.02 (2g) (b), 450.035 (1r) and 450.035 (1t) of the statutes; relating to: the administration by injection of prescribed drugs by pharmacists.

Analysis by the Legislative Reference Bureau

This bill allows a pharmacist or pharmacy student to administer an injectable prescribed drug to a patient outside of the context of teaching the patient self-administration techniques.

Under current law, a pharmacist or pharmacy student 1) may not administer by injection a prescribed drug product or device that is not a vaccine unless he or she has successfully completed a course of study and training in administration technique (training course); 2) may administer such a prescribed drug product or device only in the course of teaching self-administration techniques to a patient; and 3) must, when administering such a drug product or device, comply with requirements and procedures established in rules promulgated by the Pharmacy Examining Board. Additionally, a pharmacy student may only administer such a prescribed drug product or device under the direct supervision of a pharmacist who has also successfully completed a training course.

This bill eliminates the limitation providing that a pharmacist or pharmacy student may administer such a prescribed drug product or device only in the course of teaching self-administration techniques to a patient. However, the bill requires a pharmacist or pharmacy student, or his or her agent after the pharmacist or pharmacy student administers a prescribed drug product or device to a patient, to notify the prescribing practitioner or enter the information in a patient record system shared by the prescribing practitioner.

For further information see the state fiscal estimate, which will be printed as an appendix to this bill.

The people of the state of Wisconsin, represented in senate and assembly, do enact as follows:

SB708,1 Section 1. 450.02 (2g) (b) of the statutes, as affected by 2015 Wisconsin Act 55, is amended to read:

SB708,2,6 450.02 (2g) (b) The board shall promulgate rules that establish requirements and procedures for the administration of a drug product or device, as defined in s. 450.035 (1g), by a pharmacist under s. 450.035 (1r) or by another person under s. 450.035 (1t).

SB708,2 Section 2. 450.035 (1r) of the statutes is amended to read:

SB708,2,19 450.035 (1r) A pharmacist may not administer by injection a prescribed drug product or device unless he or she has successfully completed a course of study and training in injection administration technique conducted by a course provider approved by the Accreditation Council for Pharmacy Education or the board. A pharmacist may administer a prescribed drug product or device under this subsection only in the course of teaching self-administration techniques to a patient. A pharmacist who administers a prescribed drug product or device under this subsection shall comply with the requirements and procedures established in rules promulgated by the board under s. 450.02 (2g) (b). The pharmacist or his or her agent shall also, after the pharmacist administers a prescribed drug product or device under this subsection, notify the prescribing practitioner or enter the information in a patient record system shared by the prescribing practitioner.

SB708,3 Section 3. 450.035 (1t) of the statutes is amended to read:

SB708,3,17 450.035 (1t) A person engaged in the practice of pharmacy under s. 450.03 (1) (f) or (g) may not administer a prescribed drug product or device unless he or she has successfully completed a course of study and training in administration technique conducted by a course provider approved by the Accreditation Council for Pharmacy Education or the board. A person engaged in the practice of pharmacy under s. 450.03 (1) (f) or (g) may administer a prescribed drug product or device under this subsection only under the direct supervision of a pharmacist who has successfully completed a course of study and training in administration technique conducted by a course provider approved by the Accreditation Council for Pharmacy Education or the board, and only in the course of teaching self-administration techniques to a patient. A person engaged in the practice of pharmacy under s. 450.03 (1) (f) or (g) who administers a prescribed drug product or device under this subsection shall comply with the requirements and procedures established in rules promulgated by the board under s. 450.02 (2g) (b). The person or his or her agent shall also, after the person administers a prescribed drug product or device under this subsection, notify the prescribing practitioner or enter the information in a patient record system shared by the prescribing practitioner.

SB708,3,18 (End)